Alcon, a manufacturer, researcher, developer and marketer of surgical equipment and devices, to treat diseases, disorders and other conditions of the eye, has named Robert Karsunky as senior vice president (VP) and chief financial officer (CFO) of the company, effective 1 November 2010.

Karsunky most recently served as CFO in the Consumer Health Division of Novartis, where he took up the responsibilities of the division’s finance, information technologies, procurement and merger and acquisition activities.

Before joining Novartis, Karsunky served for four years as the VP of Finance for the international division of Medtronic.

Karsunky began his career with Eli Lilly in 1991 where he had a variety of increasingly responsible financial positions to become the executive director of Finance for Intercontinental and Japan from 2000 to 2002.

Alcon CEO Kevin Buehler said that Karsunky’s broad experience in finance and leadership roles with three health care companies will be a tremendous asset to Alcon as they execute their growth strategies.

“Furthermore, his knowledge of the Novartis organisation will be beneficial in optimising the opportunities to create value for Alcon through cooperative efforts and arm’s length agreements with our new majority shareholder,” Buehler said.